Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-02-20

AUTHORS

S De Summa, R Pinto, B Pilato, D Sambiasi, L Porcelli, G Guida, E Mattioli, A Paradiso, G Merla, L Micale, P De Nittis, S Tommasi

ABSTRACT

Understanding of BRCA1/2 interaction with the base excision repair (BER) pathway could improve therapy based on 'synthetic lethality', whose effectiveness is based on homologous recombination deficiency in cells lacking functional BRCA genes. However, poly (ADP-ribose) polymerase (PARP) inhibitors failed in some patients and for this reason we explored BER key enzyme expression. In this study, the expression of BER enzymes (redox factor 1/apurinic-apyrimidinic endonuclease 1 (REF1/APEX1), NTH endonuclease III-like 1 (NTHL1), 8-oxoguanine DNA glycosylase (OGG1), PARP1) and of the scaffold protein XRCC1 (X-ray repair complementing defective repair in Chinese hamster cells 1) were investigated in familial (BRCA-related and not) and sporadic breast cancer cases. Furthermore, miR17 expression was measured because of its role in the epigenetic regulation of BRCA1. Gene expression was evaluated in BRCA1-mutated cell lines, SUM149PT and SUM1315MO2, and in a BRCA1-proficient triple-negative MDA-MB-231 cell line. A cohort of 27 familial and 16 sporadic breast cancer patients was then examined to confirm results obtained from the cell line model. APEX1/REF1 was found to be upregulated in familial BRCA-wild-type and sporadic cases, indicating this enzyme as a potential therapeutic target. Furthermore, XRCC1 was overexpressed in BRCAX patients; consequently, we suggest to test the effectiveness of inhibitors targeting two different BER components in preclinical studies. XRCC1, which is also involved in the non-homologous end-joining pathway, was found to be downregulated in BRCA2-related patients concurrently with no change in PARP1 expression. Interestingly, no difference in PARP1 and miR17 expression was found in BRCA-related and sporadic breast cancer cases. PARP1 and miR17 could therefore be further investigated as molecular biomarkers of 'BRCAness' phenotype, indicating patients which could really benefit from PARP inhibitor therapies. More... »

PAGES

e1076

References to SciGraph publications

  • 2010-10-22. Triple-negative breast cancer in BREAST CANCER RESEARCH
  • 2012-06-08. Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells in BREAST CANCER RESEARCH AND TREATMENT
  • 2000-11-23. Reduced ligation during DNA base excision repair supported by BRCA2 mutant cells in ONCOGENE
  • 2012-06-12. Cytoplasmic Ape1 Expression Elevated by p53 Aberration May Predict Survival and Relapse in Resected Non-Small Cell Lung Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 1998-12. Genetic instabilities in human cancers in NATURE
  • 2006-03-13. Mouse models of XRCC1 DNA repair polymorphisms and cancer in ONCOGENE
  • 2005-05-09. ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines in MOLECULAR CANCER
  • 2007-08. Study of interaction of XRCC1 with DNA and proteins of base excision repair by photoaffinity labeling technique in BIOCHEMISTRY (MOSCOW)
  • 2011-07-05. Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines in BRITISH JOURNAL OF CANCER
  • 2011-06-27. MicroRNA-mediated drug resistance in breast cancer in CLINICAL EPIGENETICS
  • 2012-11-14. Molecular characterisation of cell line models for triple-negative breast cancers in BMC GENOMICS
  • 2010-11-11. Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis in BREAST CANCER RESEARCH AND TREATMENT
  • 2008-06-03. BRCA1 promoter methylation is associated with increased mortality among women with breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2006-10-02. BRCA1 dysfunction in sporadic basal-like breast cancer in ONCOGENE
  • 2002-08-26. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair in NATURE GENETICS
  • 2004-07-30. Cancer genes and the pathways they control in NATURE MEDICINE
  • Journal

    TITLE

    Cell Death & Disease

    ISSUE

    2

    VOLUME

    5

    Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/cddis.2014.30

    DOI

    http://dx.doi.org/10.1038/cddis.2014.30

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1051538197

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/24556691


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biochemistry and Cell Biology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Genetics", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "BRCA1 Protein", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "BRCA2 Protein", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biomarkers, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Computational Biology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Glycosylases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Repair", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA-(Apurinic or Apyrimidinic Site) Lyase", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA-Binding Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Databases, Genetic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Deoxyribonuclease (Pyrimidine Dimer)", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genetic Predisposition to Disease", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "HEK293 Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "MicroRNAs", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mutation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Phenotype", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Poly (ADP-Ribose) Polymerase-1", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Poly(ADP-ribose) Polymerases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transfection", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Triple Negative Breast Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "X-ray Repair Cross Complementing Protein 1", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Molecular Genetics Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.", 
              "id": "http://www.grid.ac/institutes/grid.489132.5", 
              "name": [
                "Molecular Genetics Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy."
              ], 
              "type": "Organization"
            }, 
            "familyName": "De Summa", 
            "givenName": "S", 
            "id": "sg:person.01074233520.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074233520.36"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Molecular Genetics Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.", 
              "id": "http://www.grid.ac/institutes/grid.489132.5", 
              "name": [
                "Molecular Genetics Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pinto", 
            "givenName": "R", 
            "id": "sg:person.01046456345.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046456345.77"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Molecular Genetics Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.", 
              "id": "http://www.grid.ac/institutes/grid.489132.5", 
              "name": [
                "Molecular Genetics Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pilato", 
            "givenName": "B", 
            "id": "sg:person.0720240416.24", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720240416.24"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Molecular Genetics Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.", 
              "id": "http://www.grid.ac/institutes/grid.489132.5", 
              "name": [
                "Molecular Genetics Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sambiasi", 
            "givenName": "D", 
            "id": "sg:person.01247031523.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247031523.32"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Preclinical and Clinical Pharmacology Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.", 
              "id": "http://www.grid.ac/institutes/grid.489132.5", 
              "name": [
                "Preclinical and Clinical Pharmacology Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Porcelli", 
            "givenName": "L", 
            "id": "sg:person.0657537307.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657537307.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medical Biochemistry, Medical Biology and Medical Physics, School of Medicine, University of Bari, Bari, Italy.", 
              "id": "http://www.grid.ac/institutes/grid.7644.1", 
              "name": [
                "Department of Medical Biochemistry, Medical Biology and Medical Physics, School of Medicine, University of Bari, Bari, Italy."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Guida", 
            "givenName": "G", 
            "id": "sg:person.01027360255.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027360255.43"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Anatomopathology Unit, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.", 
              "id": "http://www.grid.ac/institutes/grid.489132.5", 
              "name": [
                "Anatomopathology Unit, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mattioli", 
            "givenName": "E", 
            "id": "sg:person.01327544461.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327544461.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Experimental Medical Oncology Unit, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.", 
              "id": "http://www.grid.ac/institutes/grid.489132.5", 
              "name": [
                "Experimental Medical Oncology Unit, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Paradiso", 
            "givenName": "A", 
            "id": "sg:person.01011373127.90", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011373127.90"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medical Genetics Unit, IRCCS Casa Sollievo delle Sofferenza, San Giovanni Rotondo, Italy.", 
              "id": "http://www.grid.ac/institutes/grid.413503.0", 
              "name": [
                "Medical Genetics Unit, IRCCS Casa Sollievo delle Sofferenza, San Giovanni Rotondo, Italy."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Merla", 
            "givenName": "G", 
            "id": "sg:person.0666654566.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666654566.01"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medical Genetics Unit, IRCCS Casa Sollievo delle Sofferenza, San Giovanni Rotondo, Italy.", 
              "id": "http://www.grid.ac/institutes/grid.413503.0", 
              "name": [
                "Medical Genetics Unit, IRCCS Casa Sollievo delle Sofferenza, San Giovanni Rotondo, Italy."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Micale", 
            "givenName": "L", 
            "id": "sg:person.0746744502.41", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746744502.41"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medical Genetics Unit, IRCCS Casa Sollievo delle Sofferenza, San Giovanni Rotondo, Italy.", 
              "id": "http://www.grid.ac/institutes/grid.413503.0", 
              "name": [
                "Medical Genetics Unit, IRCCS Casa Sollievo delle Sofferenza, San Giovanni Rotondo, Italy."
              ], 
              "type": "Organization"
            }, 
            "familyName": "De Nittis", 
            "givenName": "P", 
            "id": "sg:person.0730606074.34", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730606074.34"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Molecular Genetics Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.", 
              "id": "http://www.grid.ac/institutes/grid.489132.5", 
              "name": [
                "Molecular Genetics Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tommasi", 
            "givenName": "S", 
            "id": "sg:person.0701653205.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701653205.46"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/bjc.2011.243", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017248422", 
              "https://doi.org/10.1038/bjc.2011.243"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1210014", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039037705", 
              "https://doi.org/10.1038/sj.onc.1210014"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1476-4598-4-18", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045004692", 
              "https://doi.org/10.1186/1476-4598-4-18"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1134/s000629790708010x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023874367", 
              "https://doi.org/10.1134/s000629790708010x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/25292", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033871070", 
              "https://doi.org/10.1038/25292"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10549-008-0075-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053486949", 
              "https://doi.org/10.1007/s10549-008-0075-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1209370", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039435515", 
              "https://doi.org/10.1038/sj.onc.1209370"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1471-2164-13-619", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046480543", 
              "https://doi.org/10.1186/1471-2164-13-619"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1203951", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037701395", 
              "https://doi.org/10.1038/sj.onc.1203951"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm1087", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026059473", 
              "https://doi.org/10.1038/nm1087"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10549-012-2106-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020529108", 
              "https://doi.org/10.1007/s10549-012-2106-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/bcr2574", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031566986", 
              "https://doi.org/10.1186/bcr2574"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10549-010-1199-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037212667", 
              "https://doi.org/10.1007/s10549-010-1199-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1245/s10434-012-2431-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014960126", 
              "https://doi.org/10.1245/s10434-012-2431-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s13148-011-0040-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040990399", 
              "https://doi.org/10.1007/s13148-011-0040-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ng953", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051487013", 
              "https://doi.org/10.1038/ng953"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2014-02-20", 
        "datePublishedReg": "2014-02-20", 
        "description": "Understanding of BRCA1/2 interaction with the base excision repair (BER) pathway could improve therapy based on 'synthetic lethality', whose effectiveness is based on homologous recombination deficiency in cells lacking functional BRCA genes. However, poly (ADP-ribose) polymerase (PARP) inhibitors failed in some patients and for this reason we explored BER key enzyme expression. In this study, the expression of BER enzymes (redox factor 1/apurinic-apyrimidinic endonuclease 1 (REF1/APEX1), NTH endonuclease III-like 1 (NTHL1), 8-oxoguanine DNA glycosylase (OGG1), PARP1) and of the scaffold protein XRCC1 (X-ray repair complementing defective repair in Chinese hamster cells 1) were investigated in familial (BRCA-related and not) and sporadic breast cancer cases. Furthermore, miR17 expression was measured because of its role in the epigenetic regulation of BRCA1. Gene expression was evaluated in BRCA1-mutated cell lines, SUM149PT and SUM1315MO2, and in a BRCA1-proficient triple-negative MDA-MB-231 cell line. A cohort of 27 familial and 16 sporadic breast cancer patients was then examined to confirm results obtained from the cell line model. APEX1/REF1 was found to be upregulated in familial BRCA-wild-type and sporadic cases, indicating this enzyme as a potential therapeutic target. Furthermore, XRCC1 was overexpressed in BRCAX patients; consequently, we suggest to test the effectiveness of inhibitors targeting two different BER components in preclinical studies. XRCC1, which is also involved in the non-homologous end-joining pathway, was found to be downregulated in BRCA2-related patients concurrently with no change in PARP1 expression. Interestingly, no difference in PARP1 and miR17 expression was found in BRCA-related and sporadic breast cancer cases. PARP1 and miR17 could therefore be further investigated as molecular biomarkers of 'BRCAness' phenotype, indicating patients which could really benefit from PARP inhibitor therapies. ", 
        "genre": "article", 
        "id": "sg:pub.10.1038/cddis.2014.30", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1042939", 
            "issn": [
              "2041-4889"
            ], 
            "name": "Cell Death & Disease", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "2", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "5"
          }
        ], 
        "keywords": [
          "non-homologous end-joining pathway", 
          "scaffold protein XRCC1", 
          "base excision repair pathway", 
          "end-joining pathway", 
          "excision repair pathway", 
          "cell lines", 
          "Triple-Negative MDA", 
          "protein XRCC1", 
          "key enzyme expression", 
          "BER components", 
          "epigenetic regulation", 
          "sporadic breast cancer cases", 
          "BER enzymes", 
          "repair pathways", 
          "cell line models", 
          "synthetic lethality", 
          "gene expression", 
          "potential therapeutic target", 
          "enzyme expression", 
          "MB-231 cell line", 
          "PARP1", 
          "recombination deficiency", 
          "XRCC1", 
          "expression", 
          "homologous recombination deficiency", 
          "therapeutic target", 
          "BRCAX patients", 
          "PARP1 expression", 
          "molecular biomarkers", 
          "enzyme", 
          "pathway", 
          "poly (ADP-ribose) polymerase inhibitors", 
          "sporadic breast cancer", 
          "BRCA1", 
          "effectiveness of inhibitors", 
          "SUM1315MO2", 
          "polymerase inhibitors", 
          "BRCA genes", 
          "inhibitors", 
          "SUM149PT", 
          "genes", 
          "Ref1", 
          "sporadic breast cancer patients", 
          "phenotype", 
          "lethality", 
          "regulation", 
          "breast cancer cases", 
          "lines", 
          "PARP inhibitor therapy", 
          "BRCAness", 
          "cells", 
          "BRCA2", 
          "target", 
          "sporadic cases", 
          "key factors", 
          "line model", 
          "BRCA", 
          "role", 
          "cancer cases", 
          "interaction", 
          "deficiency", 
          "breast cancer patients", 
          "understanding", 
          "breast cancer", 
          "biomarkers", 
          "cancer", 
          "MDA", 
          "inhibitor therapy", 
          "components", 
          "cancer patients", 
          "study", 
          "preclinical studies", 
          "patients", 
          "factors", 
          "changes", 
          "therapy", 
          "differences", 
          "results", 
          "cohort", 
          "cases", 
          "model", 
          "effectiveness", 
          "reasons", 
          "BRCA1/2 interaction", 
          "functional BRCA genes", 
          "BER key enzyme expression", 
          "BRCA1-proficient triple-negative MDA", 
          "APEX1/REF1", 
          "familial BRCA", 
          "different BER components", 
          "base excision repair key factors", 
          "excision repair key factors", 
          "repair key factors"
        ], 
        "name": "Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer", 
        "pagination": "e1076", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1051538197"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/cddis.2014.30"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "24556691"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/cddis.2014.30", 
          "https://app.dimensions.ai/details/publication/pub.1051538197"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-01-01T18:32", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_617.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/cddis.2014.30"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/cddis.2014.30'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/cddis.2014.30'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/cddis.2014.30'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/cddis.2014.30'


     

    This table displays all metadata directly associated to this object as RDF triples.

    431 TRIPLES      22 PREDICATES      166 URIs      139 LITERALS      35 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/cddis.2014.30 schema:about N01485abb579c4b13842a8e93a8818dd2
    2 N01e34115c43f4182b6c2e7e28c7e41d8
    3 N11b804cfdcfb446a88d488d4462e724b
    4 N1a69402dff6a4754b191ed9980a7184c
    5 N2149c6ec94c24dd49f5c69c481cb052c
    6 N2cb8d06122a6412fa0f4545592926aab
    7 N3706d9b1e2794197803e5955c25a6176
    8 N4af0c4cdb9444842a5bf5798c2a3e2f4
    9 N549dd532a8db4febacaa459e674d312b
    10 N5d3a8c3fe4954a86a4c9688f8ca32a54
    11 N6a3c389983fc4893be78d21dc24dae50
    12 N6ad375c710e4482aa637078ed38ca13d
    13 N7176d569950b499ab2c1d228aee30c86
    14 N9ff28e03ef374a9e90a9431130970698
    15 Na9effd90387242149709c5d464567e5f
    16 Nae5ef5f57c0c41f88dc636beed63b0a2
    17 Nb6ce73ecd04b41a0beed369489b5e3a8
    18 Nb9e4229a616a42b1a3858fbf6c0860d8
    19 Nba27f51fa2b843c6a97346e1e1fe14f7
    20 Nd77736380fb34de0b34b64be59e37d8a
    21 Nd9c28007775b4460985fab03e9f2723c
    22 Ndc00a130b06444118715b76d0c03209f
    23 Nddb635ccc83e4a8bb434b87db9742757
    24 Ne141a8848ec144e288b47c9fa07ae8f2
    25 Ne6a9149a7fef4282a26fe34d340d1243
    26 Neda6b0c260514c11bb81c513f01cf2ce
    27 Nf9e128816e594e74bb135ac96cb2776f
    28 Nfdd42cb292b948139f311635550c7b8c
    29 anzsrc-for:06
    30 anzsrc-for:0601
    31 anzsrc-for:0604
    32 anzsrc-for:11
    33 anzsrc-for:1112
    34 schema:author N5f5fe0b44db241689921780e68a70dd5
    35 schema:citation sg:pub.10.1007/s10549-008-0075-5
    36 sg:pub.10.1007/s10549-010-1199-y
    37 sg:pub.10.1007/s10549-012-2106-5
    38 sg:pub.10.1007/s13148-011-0040-8
    39 sg:pub.10.1038/25292
    40 sg:pub.10.1038/bjc.2011.243
    41 sg:pub.10.1038/ng953
    42 sg:pub.10.1038/nm1087
    43 sg:pub.10.1038/sj.onc.1203951
    44 sg:pub.10.1038/sj.onc.1209370
    45 sg:pub.10.1038/sj.onc.1210014
    46 sg:pub.10.1134/s000629790708010x
    47 sg:pub.10.1186/1471-2164-13-619
    48 sg:pub.10.1186/1476-4598-4-18
    49 sg:pub.10.1186/bcr2574
    50 sg:pub.10.1245/s10434-012-2431-2
    51 schema:datePublished 2014-02-20
    52 schema:datePublishedReg 2014-02-20
    53 schema:description Understanding of BRCA1/2 interaction with the base excision repair (BER) pathway could improve therapy based on 'synthetic lethality', whose effectiveness is based on homologous recombination deficiency in cells lacking functional BRCA genes. However, poly (ADP-ribose) polymerase (PARP) inhibitors failed in some patients and for this reason we explored BER key enzyme expression. In this study, the expression of BER enzymes (redox factor 1/apurinic-apyrimidinic endonuclease 1 (REF1/APEX1), NTH endonuclease III-like 1 (NTHL1), 8-oxoguanine DNA glycosylase (OGG1), PARP1) and of the scaffold protein XRCC1 (X-ray repair complementing defective repair in Chinese hamster cells 1) were investigated in familial (BRCA-related and not) and sporadic breast cancer cases. Furthermore, miR17 expression was measured because of its role in the epigenetic regulation of BRCA1. Gene expression was evaluated in BRCA1-mutated cell lines, SUM149PT and SUM1315MO2, and in a BRCA1-proficient triple-negative MDA-MB-231 cell line. A cohort of 27 familial and 16 sporadic breast cancer patients was then examined to confirm results obtained from the cell line model. APEX1/REF1 was found to be upregulated in familial BRCA-wild-type and sporadic cases, indicating this enzyme as a potential therapeutic target. Furthermore, XRCC1 was overexpressed in BRCAX patients; consequently, we suggest to test the effectiveness of inhibitors targeting two different BER components in preclinical studies. XRCC1, which is also involved in the non-homologous end-joining pathway, was found to be downregulated in BRCA2-related patients concurrently with no change in PARP1 expression. Interestingly, no difference in PARP1 and miR17 expression was found in BRCA-related and sporadic breast cancer cases. PARP1 and miR17 could therefore be further investigated as molecular biomarkers of 'BRCAness' phenotype, indicating patients which could really benefit from PARP inhibitor therapies.
    54 schema:genre article
    55 schema:inLanguage en
    56 schema:isAccessibleForFree true
    57 schema:isPartOf N75f07882ac9441c49cc5bcf77d6beac2
    58 Nfae8b1e963794ee98fa74b069d2f9342
    59 sg:journal.1042939
    60 schema:keywords APEX1/REF1
    61 BER components
    62 BER enzymes
    63 BER key enzyme expression
    64 BRCA
    65 BRCA genes
    66 BRCA1
    67 BRCA1-proficient triple-negative MDA
    68 BRCA1/2 interaction
    69 BRCA2
    70 BRCAX patients
    71 BRCAness
    72 MB-231 cell line
    73 MDA
    74 PARP inhibitor therapy
    75 PARP1
    76 PARP1 expression
    77 Ref1
    78 SUM1315MO2
    79 SUM149PT
    80 Triple-Negative MDA
    81 XRCC1
    82 base excision repair key factors
    83 base excision repair pathway
    84 biomarkers
    85 breast cancer
    86 breast cancer cases
    87 breast cancer patients
    88 cancer
    89 cancer cases
    90 cancer patients
    91 cases
    92 cell line models
    93 cell lines
    94 cells
    95 changes
    96 cohort
    97 components
    98 deficiency
    99 differences
    100 different BER components
    101 effectiveness
    102 effectiveness of inhibitors
    103 end-joining pathway
    104 enzyme
    105 enzyme expression
    106 epigenetic regulation
    107 excision repair key factors
    108 excision repair pathway
    109 expression
    110 factors
    111 familial BRCA
    112 functional BRCA genes
    113 gene expression
    114 genes
    115 homologous recombination deficiency
    116 inhibitor therapy
    117 inhibitors
    118 interaction
    119 key enzyme expression
    120 key factors
    121 lethality
    122 line model
    123 lines
    124 model
    125 molecular biomarkers
    126 non-homologous end-joining pathway
    127 pathway
    128 patients
    129 phenotype
    130 poly (ADP-ribose) polymerase inhibitors
    131 polymerase inhibitors
    132 potential therapeutic target
    133 preclinical studies
    134 protein XRCC1
    135 reasons
    136 recombination deficiency
    137 regulation
    138 repair key factors
    139 repair pathways
    140 results
    141 role
    142 scaffold protein XRCC1
    143 sporadic breast cancer
    144 sporadic breast cancer cases
    145 sporadic breast cancer patients
    146 sporadic cases
    147 study
    148 synthetic lethality
    149 target
    150 therapeutic target
    151 therapy
    152 understanding
    153 schema:name Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer
    154 schema:pagination e1076
    155 schema:productId N009e8775293d4a5b9b604c864647aa1e
    156 N91d88d43ce784148a4c4f438f6051ede
    157 Nc43d3bd00cf44b48b3fa2d3a64dc3d8f
    158 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051538197
    159 https://doi.org/10.1038/cddis.2014.30
    160 schema:sdDatePublished 2022-01-01T18:32
    161 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    162 schema:sdPublisher N0098a1f77ccf47c9b50e8e91fed8ff37
    163 schema:url https://doi.org/10.1038/cddis.2014.30
    164 sgo:license sg:explorer/license/
    165 sgo:sdDataset articles
    166 rdf:type schema:ScholarlyArticle
    167 N0098a1f77ccf47c9b50e8e91fed8ff37 schema:name Springer Nature - SN SciGraph project
    168 rdf:type schema:Organization
    169 N009e8775293d4a5b9b604c864647aa1e schema:name doi
    170 schema:value 10.1038/cddis.2014.30
    171 rdf:type schema:PropertyValue
    172 N01485abb579c4b13842a8e93a8818dd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Poly (ADP-Ribose) Polymerase-1
    174 rdf:type schema:DefinedTerm
    175 N01e34115c43f4182b6c2e7e28c7e41d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Deoxyribonuclease (Pyrimidine Dimer)
    177 rdf:type schema:DefinedTerm
    178 N02046ac6578f48bf9b9c4ab386b1acc1 rdf:first sg:person.01011373127.90
    179 rdf:rest Nd21ec4ed1fa341aa8e4d5064bb332df3
    180 N11b804cfdcfb446a88d488d4462e724b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    181 schema:name Triple Negative Breast Neoplasms
    182 rdf:type schema:DefinedTerm
    183 N1a69402dff6a4754b191ed9980a7184c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    184 schema:name Poly(ADP-ribose) Polymerases
    185 rdf:type schema:DefinedTerm
    186 N2149c6ec94c24dd49f5c69c481cb052c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    187 schema:name Mutation
    188 rdf:type schema:DefinedTerm
    189 N2cb8d06122a6412fa0f4545592926aab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name DNA Glycosylases
    191 rdf:type schema:DefinedTerm
    192 N34412628f508432f86edb2f5e7ba9302 rdf:first sg:person.0701653205.46
    193 rdf:rest rdf:nil
    194 N3706d9b1e2794197803e5955c25a6176 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    195 schema:name HEK293 Cells
    196 rdf:type schema:DefinedTerm
    197 N4af0c4cdb9444842a5bf5798c2a3e2f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    198 schema:name Adult
    199 rdf:type schema:DefinedTerm
    200 N549dd532a8db4febacaa459e674d312b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    201 schema:name MicroRNAs
    202 rdf:type schema:DefinedTerm
    203 N5d3a8c3fe4954a86a4c9688f8ca32a54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    204 schema:name Female
    205 rdf:type schema:DefinedTerm
    206 N5f5fe0b44db241689921780e68a70dd5 rdf:first sg:person.01074233520.36
    207 rdf:rest Nb20dd1cf370244e6abe8ca3875b1197e
    208 N6a3c389983fc4893be78d21dc24dae50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    209 schema:name X-ray Repair Cross Complementing Protein 1
    210 rdf:type schema:DefinedTerm
    211 N6ad375c710e4482aa637078ed38ca13d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    212 schema:name Aged
    213 rdf:type schema:DefinedTerm
    214 N7176d569950b499ab2c1d228aee30c86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    215 schema:name Mice
    216 rdf:type schema:DefinedTerm
    217 N71db839eb00d42f1b10d7421a66e8215 rdf:first sg:person.0746744502.41
    218 rdf:rest N9f5302f97d924614a8a07a510d582df3
    219 N72db2b99deea4a36805d537c8ebfeae5 rdf:first sg:person.0720240416.24
    220 rdf:rest Ne244924caa5f47fbaabf9d4704fa7b4a
    221 N75f07882ac9441c49cc5bcf77d6beac2 schema:volumeNumber 5
    222 rdf:type schema:PublicationVolume
    223 N91d88d43ce784148a4c4f438f6051ede schema:name pubmed_id
    224 schema:value 24556691
    225 rdf:type schema:PropertyValue
    226 N9f5302f97d924614a8a07a510d582df3 rdf:first sg:person.0730606074.34
    227 rdf:rest N34412628f508432f86edb2f5e7ba9302
    228 N9ff28e03ef374a9e90a9431130970698 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    229 schema:name Transfection
    230 rdf:type schema:DefinedTerm
    231 Na914fc16769b49929dcb6a31766436fa rdf:first sg:person.01027360255.43
    232 rdf:rest Ne6039488b27147d48a58109bd8509a9b
    233 Na9effd90387242149709c5d464567e5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    234 schema:name Middle Aged
    235 rdf:type schema:DefinedTerm
    236 Nae5ef5f57c0c41f88dc636beed63b0a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    237 schema:name Humans
    238 rdf:type schema:DefinedTerm
    239 Naeff201b208549fb965b3725ef5ec1ac rdf:first sg:person.0657537307.14
    240 rdf:rest Na914fc16769b49929dcb6a31766436fa
    241 Nb20dd1cf370244e6abe8ca3875b1197e rdf:first sg:person.01046456345.77
    242 rdf:rest N72db2b99deea4a36805d537c8ebfeae5
    243 Nb6ce73ecd04b41a0beed369489b5e3a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    244 schema:name DNA Repair
    245 rdf:type schema:DefinedTerm
    246 Nb9e4229a616a42b1a3858fbf6c0860d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    247 schema:name DNA-Binding Proteins
    248 rdf:type schema:DefinedTerm
    249 Nba27f51fa2b843c6a97346e1e1fe14f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    250 schema:name Biomarkers, Tumor
    251 rdf:type schema:DefinedTerm
    252 Nc43d3bd00cf44b48b3fa2d3a64dc3d8f schema:name dimensions_id
    253 schema:value pub.1051538197
    254 rdf:type schema:PropertyValue
    255 Nd21ec4ed1fa341aa8e4d5064bb332df3 rdf:first sg:person.0666654566.01
    256 rdf:rest N71db839eb00d42f1b10d7421a66e8215
    257 Nd77736380fb34de0b34b64be59e37d8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    258 schema:name Databases, Genetic
    259 rdf:type schema:DefinedTerm
    260 Nd9c28007775b4460985fab03e9f2723c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    261 schema:name BRCA2 Protein
    262 rdf:type schema:DefinedTerm
    263 Ndc00a130b06444118715b76d0c03209f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    264 schema:name Phenotype
    265 rdf:type schema:DefinedTerm
    266 Nddb635ccc83e4a8bb434b87db9742757 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    267 schema:name DNA-(Apurinic or Apyrimidinic Site) Lyase
    268 rdf:type schema:DefinedTerm
    269 Ne141a8848ec144e288b47c9fa07ae8f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    270 schema:name BRCA1 Protein
    271 rdf:type schema:DefinedTerm
    272 Ne244924caa5f47fbaabf9d4704fa7b4a rdf:first sg:person.01247031523.32
    273 rdf:rest Naeff201b208549fb965b3725ef5ec1ac
    274 Ne6039488b27147d48a58109bd8509a9b rdf:first sg:person.01327544461.07
    275 rdf:rest N02046ac6578f48bf9b9c4ab386b1acc1
    276 Ne6a9149a7fef4282a26fe34d340d1243 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    277 schema:name Genetic Predisposition to Disease
    278 rdf:type schema:DefinedTerm
    279 Neda6b0c260514c11bb81c513f01cf2ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    280 schema:name Animals
    281 rdf:type schema:DefinedTerm
    282 Nf9e128816e594e74bb135ac96cb2776f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    283 schema:name Computational Biology
    284 rdf:type schema:DefinedTerm
    285 Nfae8b1e963794ee98fa74b069d2f9342 schema:issueNumber 2
    286 rdf:type schema:PublicationIssue
    287 Nfdd42cb292b948139f311635550c7b8c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    288 schema:name Cell Line, Tumor
    289 rdf:type schema:DefinedTerm
    290 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    291 schema:name Biological Sciences
    292 rdf:type schema:DefinedTerm
    293 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
    294 schema:name Biochemistry and Cell Biology
    295 rdf:type schema:DefinedTerm
    296 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
    297 schema:name Genetics
    298 rdf:type schema:DefinedTerm
    299 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    300 schema:name Medical and Health Sciences
    301 rdf:type schema:DefinedTerm
    302 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    303 schema:name Oncology and Carcinogenesis
    304 rdf:type schema:DefinedTerm
    305 sg:journal.1042939 schema:issn 2041-4889
    306 schema:name Cell Death & Disease
    307 schema:publisher Springer Nature
    308 rdf:type schema:Periodical
    309 sg:person.01011373127.90 schema:affiliation grid-institutes:grid.489132.5
    310 schema:familyName Paradiso
    311 schema:givenName A
    312 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011373127.90
    313 rdf:type schema:Person
    314 sg:person.01027360255.43 schema:affiliation grid-institutes:grid.7644.1
    315 schema:familyName Guida
    316 schema:givenName G
    317 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027360255.43
    318 rdf:type schema:Person
    319 sg:person.01046456345.77 schema:affiliation grid-institutes:grid.489132.5
    320 schema:familyName Pinto
    321 schema:givenName R
    322 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046456345.77
    323 rdf:type schema:Person
    324 sg:person.01074233520.36 schema:affiliation grid-institutes:grid.489132.5
    325 schema:familyName De Summa
    326 schema:givenName S
    327 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074233520.36
    328 rdf:type schema:Person
    329 sg:person.01247031523.32 schema:affiliation grid-institutes:grid.489132.5
    330 schema:familyName Sambiasi
    331 schema:givenName D
    332 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247031523.32
    333 rdf:type schema:Person
    334 sg:person.01327544461.07 schema:affiliation grid-institutes:grid.489132.5
    335 schema:familyName Mattioli
    336 schema:givenName E
    337 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327544461.07
    338 rdf:type schema:Person
    339 sg:person.0657537307.14 schema:affiliation grid-institutes:grid.489132.5
    340 schema:familyName Porcelli
    341 schema:givenName L
    342 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657537307.14
    343 rdf:type schema:Person
    344 sg:person.0666654566.01 schema:affiliation grid-institutes:grid.413503.0
    345 schema:familyName Merla
    346 schema:givenName G
    347 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666654566.01
    348 rdf:type schema:Person
    349 sg:person.0701653205.46 schema:affiliation grid-institutes:grid.489132.5
    350 schema:familyName Tommasi
    351 schema:givenName S
    352 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701653205.46
    353 rdf:type schema:Person
    354 sg:person.0720240416.24 schema:affiliation grid-institutes:grid.489132.5
    355 schema:familyName Pilato
    356 schema:givenName B
    357 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720240416.24
    358 rdf:type schema:Person
    359 sg:person.0730606074.34 schema:affiliation grid-institutes:grid.413503.0
    360 schema:familyName De Nittis
    361 schema:givenName P
    362 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730606074.34
    363 rdf:type schema:Person
    364 sg:person.0746744502.41 schema:affiliation grid-institutes:grid.413503.0
    365 schema:familyName Micale
    366 schema:givenName L
    367 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746744502.41
    368 rdf:type schema:Person
    369 sg:pub.10.1007/s10549-008-0075-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053486949
    370 https://doi.org/10.1007/s10549-008-0075-5
    371 rdf:type schema:CreativeWork
    372 sg:pub.10.1007/s10549-010-1199-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1037212667
    373 https://doi.org/10.1007/s10549-010-1199-y
    374 rdf:type schema:CreativeWork
    375 sg:pub.10.1007/s10549-012-2106-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020529108
    376 https://doi.org/10.1007/s10549-012-2106-5
    377 rdf:type schema:CreativeWork
    378 sg:pub.10.1007/s13148-011-0040-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040990399
    379 https://doi.org/10.1007/s13148-011-0040-8
    380 rdf:type schema:CreativeWork
    381 sg:pub.10.1038/25292 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033871070
    382 https://doi.org/10.1038/25292
    383 rdf:type schema:CreativeWork
    384 sg:pub.10.1038/bjc.2011.243 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017248422
    385 https://doi.org/10.1038/bjc.2011.243
    386 rdf:type schema:CreativeWork
    387 sg:pub.10.1038/ng953 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051487013
    388 https://doi.org/10.1038/ng953
    389 rdf:type schema:CreativeWork
    390 sg:pub.10.1038/nm1087 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026059473
    391 https://doi.org/10.1038/nm1087
    392 rdf:type schema:CreativeWork
    393 sg:pub.10.1038/sj.onc.1203951 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037701395
    394 https://doi.org/10.1038/sj.onc.1203951
    395 rdf:type schema:CreativeWork
    396 sg:pub.10.1038/sj.onc.1209370 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039435515
    397 https://doi.org/10.1038/sj.onc.1209370
    398 rdf:type schema:CreativeWork
    399 sg:pub.10.1038/sj.onc.1210014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039037705
    400 https://doi.org/10.1038/sj.onc.1210014
    401 rdf:type schema:CreativeWork
    402 sg:pub.10.1134/s000629790708010x schema:sameAs https://app.dimensions.ai/details/publication/pub.1023874367
    403 https://doi.org/10.1134/s000629790708010x
    404 rdf:type schema:CreativeWork
    405 sg:pub.10.1186/1471-2164-13-619 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046480543
    406 https://doi.org/10.1186/1471-2164-13-619
    407 rdf:type schema:CreativeWork
    408 sg:pub.10.1186/1476-4598-4-18 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045004692
    409 https://doi.org/10.1186/1476-4598-4-18
    410 rdf:type schema:CreativeWork
    411 sg:pub.10.1186/bcr2574 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031566986
    412 https://doi.org/10.1186/bcr2574
    413 rdf:type schema:CreativeWork
    414 sg:pub.10.1245/s10434-012-2431-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014960126
    415 https://doi.org/10.1245/s10434-012-2431-2
    416 rdf:type schema:CreativeWork
    417 grid-institutes:grid.413503.0 schema:alternateName Medical Genetics Unit, IRCCS Casa Sollievo delle Sofferenza, San Giovanni Rotondo, Italy.
    418 schema:name Medical Genetics Unit, IRCCS Casa Sollievo delle Sofferenza, San Giovanni Rotondo, Italy.
    419 rdf:type schema:Organization
    420 grid-institutes:grid.489132.5 schema:alternateName Anatomopathology Unit, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
    421 Experimental Medical Oncology Unit, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
    422 Molecular Genetics Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
    423 Preclinical and Clinical Pharmacology Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
    424 schema:name Anatomopathology Unit, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
    425 Experimental Medical Oncology Unit, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
    426 Molecular Genetics Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
    427 Preclinical and Clinical Pharmacology Laboratory, National Cancer Research Centre, Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
    428 rdf:type schema:Organization
    429 grid-institutes:grid.7644.1 schema:alternateName Department of Medical Biochemistry, Medical Biology and Medical Physics, School of Medicine, University of Bari, Bari, Italy.
    430 schema:name Department of Medical Biochemistry, Medical Biology and Medical Physics, School of Medicine, University of Bari, Bari, Italy.
    431 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...